Ketamine Treatment as the Safest Long-Term Procedure

Yale Study Confirms Ketamine Treatment as the Safest Long-Term Procedure

Researchers at Yale recently published a study called ‘Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment’. Back in 2014, Yale provided Ketamine therapy as an off-label procedure to different patients and on a case-to-case basis.

As per the Samuel T. Wilkinson, MD at Yale School of Medicine and Psychiatric Hospital;

Ketamine has been used as an off-label procedure to treat depression by many providers. Indeed, there is a very small amount of long-term data on individuals who received Ketamine therapy for more than a few weeks.

Thus, researchers at Yale studied the longer-term and acute outcomes in their patients’ population. Majorly a subset of patients (n=14) was given Ketamine for a long period of time, ranging from 13 to 45 treatments and over a course of 15 to 125 weeks.

As per the researchers, they found no cognitive decline evidence, more proclivities to delusions, or occurrence of symptoms, which are consistent with cystitis in the specific subset of patients. Also, the infusions were well-tolerated by patients.

Even though the study population is relatively small and limits the final conclusion, it is still a very important first step to establish that long-term Ketamine treatment is safe enough to treat myriad of diseases, which it’s already being used to treat.

Ketamine therapy is the most preferred treatment for individuals who suffer from chronic depression and have stopped to respond to antidepressants. The therapy consists of multiple sessions, although, the results can be observed just after the first session.

The effectiveness of the Ketamine therapy also depends upon the experience of the professional performing the procedure. If you or anyone you know is suffering from treatment-resistant depression, don’t hesitate to make an appointment with a reputed psychiatrist to start the therapy right away.